The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cardiopulmonary Autotransfusion Systems Market Research Report 2024
Synopsis
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The global Cardiopulmonary Autotransfusion Systems market was valued at US$ 553 million in 2023 and is anticipated to reach US$ 655.2 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Cardiopulmonary Autotransfusion Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Autotransfusion Systems.
Report Scope
The Cardiopulmonary Autotransfusion Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiopulmonary Autotransfusion Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiopulmonary Autotransfusion Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Advancis Surgical
Fresenius Kabi
Haemonetics
LivaNova
Medtronic
Terumo
Atrium Medical
Global Blood Resources
Redax
Sarstedt
Stryker
Segment by Type
Unwashed ATS
Washed ATS
Segment by Application
Heart Surgery
Great Organ Transplant Surgery
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiopulmonary Autotransfusion Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardiopulmonary Autotransfusion Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The global Cardiopulmonary Autotransfusion Systems market was valued at US$ 553 million in 2023 and is anticipated to reach US$ 655.2 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Cardiopulmonary Autotransfusion Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Autotransfusion Systems.
Report Scope
The Cardiopulmonary Autotransfusion Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiopulmonary Autotransfusion Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiopulmonary Autotransfusion Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Advancis Surgical
Fresenius Kabi
Haemonetics
LivaNova
Medtronic
Terumo
Atrium Medical
Global Blood Resources
Redax
Sarstedt
Stryker
Segment by Type
Unwashed ATS
Washed ATS
Segment by Application
Heart Surgery
Great Organ Transplant Surgery
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiopulmonary Autotransfusion Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardiopulmonary Autotransfusion Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cardiopulmonary Autotransfusion Systems Market Overview
1.1 Product Overview and Scope of Cardiopulmonary Autotransfusion Systems
1.2 Cardiopulmonary Autotransfusion Systems Segment by Type
1.2.1 Global Cardiopulmonary Autotransfusion Systems Market Value Comparison by Type (2024-2030)
1.2.2 Unwashed ATS
1.2.3 Washed ATS
1.3 Cardiopulmonary Autotransfusion Systems Segment by Application
1.3.1 Global Cardiopulmonary Autotransfusion Systems Market Value by Application: (2024-2030)
1.3.2 Heart Surgery
1.3.3 Great Organ Transplant Surgery
1.3.4 Others
1.4 Global Cardiopulmonary Autotransfusion Systems Market Size Estimates and Forecasts
1.4.1 Global Cardiopulmonary Autotransfusion Systems Revenue 2019-2030
1.4.2 Global Cardiopulmonary Autotransfusion Systems Sales 2019-2030
1.4.3 Global Cardiopulmonary Autotransfusion Systems Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cardiopulmonary Autotransfusion Systems Market Competition by Manufacturers
2.1 Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cardiopulmonary Autotransfusion Systems Average Price by Manufacturers (2019-2024)
2.4 Global Cardiopulmonary Autotransfusion Systems Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cardiopulmonary Autotransfusion Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiopulmonary Autotransfusion Systems, Product Type & Application
2.7 Cardiopulmonary Autotransfusion Systems Market Competitive Situation and Trends
2.7.1 Cardiopulmonary Autotransfusion Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cardiopulmonary Autotransfusion Systems Players Market Share by Revenue
2.7.3 Global Cardiopulmonary Autotransfusion Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cardiopulmonary Autotransfusion Systems Retrospective Market Scenario by Region
3.1 Global Cardiopulmonary Autotransfusion Systems Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cardiopulmonary Autotransfusion Systems Global Cardiopulmonary Autotransfusion Systems Sales by Region: 2019-2030
3.2.1 Global Cardiopulmonary Autotransfusion Systems Sales by Region: 2019-2024
3.2.2 Global Cardiopulmonary Autotransfusion Systems Sales by Region: 2025-2030
3.3 Global Cardiopulmonary Autotransfusion Systems Global Cardiopulmonary Autotransfusion Systems Revenue by Region: 2019-2030
3.3.1 Global Cardiopulmonary Autotransfusion Systems Revenue by Region: 2019-2024
3.3.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Region: 2025-2030
3.4 North America Cardiopulmonary Autotransfusion Systems Market Facts & Figures by Country
3.4.1 North America Cardiopulmonary Autotransfusion Systems Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cardiopulmonary Autotransfusion Systems Sales by Country (2019-2030)
3.4.3 North America Cardiopulmonary Autotransfusion Systems Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cardiopulmonary Autotransfusion Systems Market Facts & Figures by Country
3.5.1 Europe Cardiopulmonary Autotransfusion Systems Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cardiopulmonary Autotransfusion Systems Sales by Country (2019-2030)
3.5.3 Europe Cardiopulmonary Autotransfusion Systems Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiopulmonary Autotransfusion Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Cardiopulmonary Autotransfusion Systems Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cardiopulmonary Autotransfusion Systems Sales by Country (2019-2030)
3.6.3 Asia Pacific Cardiopulmonary Autotransfusion Systems Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cardiopulmonary Autotransfusion Systems Market Facts & Figures by Country
3.7.1 Latin America Cardiopulmonary Autotransfusion Systems Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cardiopulmonary Autotransfusion Systems Sales by Country (2019-2030)
3.7.3 Latin America Cardiopulmonary Autotransfusion Systems Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiopulmonary Autotransfusion Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiopulmonary Autotransfusion Systems Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cardiopulmonary Autotransfusion Systems Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cardiopulmonary Autotransfusion Systems Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cardiopulmonary Autotransfusion Systems Sales by Type (2019-2030)
4.1.1 Global Cardiopulmonary Autotransfusion Systems Sales by Type (2019-2024)
4.1.2 Global Cardiopulmonary Autotransfusion Systems Sales by Type (2025-2030)
4.1.3 Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Type (2019-2030)
4.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Type (2019-2030)
4.2.1 Global Cardiopulmonary Autotransfusion Systems Revenue by Type (2019-2024)
4.2.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Type (2025-2030)
4.2.3 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Type (2019-2030)
4.3 Global Cardiopulmonary Autotransfusion Systems Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cardiopulmonary Autotransfusion Systems Sales by Application (2019-2030)
5.1.1 Global Cardiopulmonary Autotransfusion Systems Sales by Application (2019-2024)
5.1.2 Global Cardiopulmonary Autotransfusion Systems Sales by Application (2025-2030)
5.1.3 Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Application (2019-2030)
5.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Application (2019-2030)
5.2.1 Global Cardiopulmonary Autotransfusion Systems Revenue by Application (2019-2024)
5.2.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Application (2025-2030)
5.2.3 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Application (2019-2030)
5.3 Global Cardiopulmonary Autotransfusion Systems Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Advancis Surgical
6.1.1 Advancis Surgical Corporation Information
6.1.2 Advancis Surgical Description and Business Overview
6.1.3 Advancis Surgical Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Advancis Surgical Cardiopulmonary Autotransfusion Systems Product Portfolio
6.1.5 Advancis Surgical Recent Developments/Updates
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Corporation Information
6.2.2 Fresenius Kabi Description and Business Overview
6.2.3 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Product Portfolio
6.2.5 Fresenius Kabi Recent Developments/Updates
6.3 Haemonetics
6.3.1 Haemonetics Corporation Information
6.3.2 Haemonetics Description and Business Overview
6.3.3 Haemonetics Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Haemonetics Cardiopulmonary Autotransfusion Systems Product Portfolio
6.3.5 Haemonetics Recent Developments/Updates
6.4 LivaNova
6.4.1 LivaNova Corporation Information
6.4.2 LivaNova Description and Business Overview
6.4.3 LivaNova Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LivaNova Cardiopulmonary Autotransfusion Systems Product Portfolio
6.4.5 LivaNova Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Corporation Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Medtronic Cardiopulmonary Autotransfusion Systems Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Terumo Cardiopulmonary Autotransfusion Systems Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 Atrium Medical
6.6.1 Atrium Medical Corporation Information
6.6.2 Atrium Medical Description and Business Overview
6.6.3 Atrium Medical Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Atrium Medical Cardiopulmonary Autotransfusion Systems Product Portfolio
6.7.5 Atrium Medical Recent Developments/Updates
6.8 Global Blood Resources
6.8.1 Global Blood Resources Corporation Information
6.8.2 Global Blood Resources Description and Business Overview
6.8.3 Global Blood Resources Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Global Blood Resources Cardiopulmonary Autotransfusion Systems Product Portfolio
6.8.5 Global Blood Resources Recent Developments/Updates
6.9 Redax
6.9.1 Redax Corporation Information
6.9.2 Redax Description and Business Overview
6.9.3 Redax Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Redax Cardiopulmonary Autotransfusion Systems Product Portfolio
6.9.5 Redax Recent Developments/Updates
6.10 Sarstedt
6.10.1 Sarstedt Corporation Information
6.10.2 Sarstedt Description and Business Overview
6.10.3 Sarstedt Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sarstedt Cardiopulmonary Autotransfusion Systems Product Portfolio
6.10.5 Sarstedt Recent Developments/Updates
6.11 Stryker
6.11.1 Stryker Corporation Information
6.11.2 Stryker Cardiopulmonary Autotransfusion Systems Description and Business Overview
6.11.3 Stryker Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Stryker Cardiopulmonary Autotransfusion Systems Product Portfolio
6.11.5 Stryker Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiopulmonary Autotransfusion Systems Industry Chain Analysis
7.2 Cardiopulmonary Autotransfusion Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiopulmonary Autotransfusion Systems Production Mode & Process
7.4 Cardiopulmonary Autotransfusion Systems Sales and Marketing
7.4.1 Cardiopulmonary Autotransfusion Systems Sales Channels
7.4.2 Cardiopulmonary Autotransfusion Systems Distributors
7.5 Cardiopulmonary Autotransfusion Systems Customers
8 Cardiopulmonary Autotransfusion Systems Market Dynamics
8.1 Cardiopulmonary Autotransfusion Systems Industry Trends
8.2 Cardiopulmonary Autotransfusion Systems Market Drivers
8.3 Cardiopulmonary Autotransfusion Systems Market Challenges
8.4 Cardiopulmonary Autotransfusion Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
